Morrison & Foerster advised Crinetics Pharmaceuticals, Inc. on the offering, Wilson Sonsini Goodrich & Rosati advised Crinetics on patent matters and Cooley advised the underwriters. Crinetics...
You must be a Standard 1 Year member to access this content.
Cooley advised Radionetics Oncology on the transaction, and Wilson Sonsini Goodrich & Rosati acted as patent counsel for Radionetics Oncology and advised the company on patent....
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Venrock on IP related matters related to the transaction. Lycia Therapeutics, Inc., a biotechnology company, announced it raised $106.6 million...
You must be a Standard 1 Year member to access this content.
Jones Day and Cooley are representing Reneo Pharmaceuticals, Inc. in the transaction, and Wilson Sonsini Goodrich & Rosati, P.C. is representing OnKure, Inc. Covington & Burling...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company, announced the close of a $103 million Series A...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised vTv Therapeutics on patent matters related to the transaction. vTv Therapeutics, a clinical-stage biopharmaceutical company, announced the closing of a private...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Radionetics Oncology on IP matters related to the transaction. Radionetics Oncology announced that it has raised $52.5 million in Series...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Metacrine on the deal. Equillium, Inc. and Metacrine Inc. announced that the two companies have entered into a definitive merger agreement pursuant to...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Crinetics on the deal. Crinetics Pharmaceuticals, a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Amplyx Pharmaceuticals on the deal. Pfizer Inc. announced that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represents the underwriters in the offering while Wilson Sonsini Goodrich & Rosati advised Reneo Pharmaceuticals, Inc. Reneo Pharmaceuticals, Inc. has announced the pricing...
You must be a Standard 1 Year member to access this content.
